(Q45265358)

11 December 2017

Fluoroquinolone use is the predominant risk factor for the development of a new strain of clostridium difficile-associated disease (English)

1 reference

11 December 2017

Clostridium difficile

0 references

author name string

Nilay S Patel

series ordinal

1

1 reference

11 December 2017

16 January 2007

1 reference

11 December 2017

1 reference

11 December 2017

99

1 reference

11 December 2017

6

1 reference

11 December 2017

1333-1334

1 reference

Emergence of Clostridium difficile-associated disease in North America and Europe.

11 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06741.X

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06741.X

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06741.X

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06741.X

Fluoroquinolone prescribing in the United States: 1995 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06741.X

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06741.X

10.1111/J.1464-410X.2006.06741.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference

PubMed ID

17233799